(Press-News.org) VIDEO:
Through the serendipity of science, researchers at the University of Pittsburgh have discovered a potential treatment for deadly, drug-resistant bacterial infections that uses the same approach that HIV uses to...
Click here for more information.
Through the serendipity of science, researchers at the University of Pittsburgh have discovered a potential treatment for deadly, drug-resistant bacterial infections that uses the same approach that HIV uses to infect cells.
The National Institutes of Health-supported discovery will be described in the June issue of the journal Antimicrobial Agents and Chemotherapy. It is especially promising in the development of a potential treatment for lung infections in people with cystic fibrosis.
"The discovery of this new antibiotic was an unexpected result of basic research on HIV proteins," said senior author Ronald Montelaro, Ph.D., professor and co-director of Pitt's Center for Vaccine Research (CVR). "As a result of studying these proteins, we discovered novel structures that turn out to work very well against bacterial infections, including the complicated bacterial populations in lung infections in cystic fibrosis patients."
Cystic fibrosis is a genetic disorder that leads to thick, viscous secretions in the lungs and other organs in about 30,000 children and adults in the United States, according to the Cystic Fibrosis Foundation. Lung infections resistant to antibiotics often are deadly for people with cystic fibrosis. About 80 percent of cystic fibrosis patients have at least one antibiotic-resistant infection in their lungs by age 18.
"Infections with progressively resistant bacteria in the lung shorten the lives of people with cystic fibrosis," said Joseph M. Pilewski, M.D., co-director of the Adult Cystic Fibrosis Center at UPMC. "What happens is the genetic defect predisposes patients to infections that drive the production of mucus that then blocks the airways and makes it difficult to breath."
Dr. Montelaro and his colleagues found that a particular sequence of amino acids on the tail end of HIV allow the virus to "punch into" and infect cells. The team manufactured a synthetic and more efficient version of this sequence – called engineered cationic antimicrobial peptides, or "eCAPs" – that laboratory tests have shown to rapidly destroy bacteria that are otherwise resistant to most standard antibiotics.
The eCAPs can be assembled in a laboratory setting from the amino acids arginine and tryptophan and manufactured to the shortest effective length, giving the resulting antibiotic treatment maximum potency while reducing costs.
The discovery was featured in April at two prestigious gatherings intended to put scientists in touch with business developers -- the BIO International Convention in Chicago, and the University Research & Entrepreneurship Symposium (URES) in Boston.
"At both symposia, we received a lot of interest from pharmaceutical-related companies," said co-author Jonathan Steckbeck, Ph.D., M.B.A., post-doctoral associate at CVR. "It was a particular honor to be recognized at URES as one of the year's 10 breakthroughs in life sciences."
Pitt has taken out several U.S. and international patents on this discovery.
"We have an unmet clinical need for treatment of hospital-acquired infections where the bacteria are extremely resistant to antibiotics," said co-author Yohei Doi, M.D., Ph.D., assistant professor of medicine in Pitt's School of Medicine. "We have patients with no treatment options left. The fact that these eCAPs are completely engineered puts them at an advantage because they can be manufactured easily, and they give us some hope for a quick-acting treatment in these dire circumstances."
Traditional antibiotics typically work by poisoning important metabolic processes after being taken up by the target bacteria, a process that may take hours, or days, to clear a bacterial infection. In contrast, the eCAPs are specifically attracted to the surface of target bacteria where they disrupt the bacterial membrane, causing death within seconds, or minutes.
Laboratory tests indicate that the eCAPs work well against biofilms, which are bacterial communities that develop very high levels of resistance to antibiotics by working together to protect the film's inner bacteria from traditional treatments. The eCAPs seem to push through the outer layers of biofilms to destroy the entire bacterial community.
"It's like a pin bursting a balloon; it's a very rapid action," said Dr. Montelaro. "While cystic fibrosis patients are our initial target and a very high-priority target, we also could look at infections associated with burns or indwelling medical devices, such as venous catheters. We could even look to the biodefense realm, in terms of a rapid, handheld nebulizer treatment that soldiers could use in the case of exposure to a bioterrorism agent."
###
Additional co-authors are Berthony Deslouches, M.D., Ph.D., and Jodi Craigo, Ph.D., both of Pitt's Center for Vaccine Research; and Timothy A. Mietzner, Ph.D., of the Lake Erie College of Osteopathic Medicine at Seton Hill.
Funding for this study was provided by NIH award P30CA047904.
A video of the researchers discussing the eCAPs is available at http://www.youtube.com/watch?v=9lM8O6AOgyw&feature=youtu.be.
END
DURHAM, N.C. -- A seven-year quest to understand how breast cancer cells resist treatment with the targeted therapy lapatinib has revealed a previously unknown molecular network that regulates cell death. The discovery provides new avenues to overcome drug resistance, according to researchers at Duke Cancer Institute.
"We've revealed multiple new signaling pathways that regulate cell death," said Sally Kornbluth, PhD, vice dean of Basic Science and professor of Pharmacology and Cancer Biology at Duke University School of Medicine. "And we've shown, at least in one disease, ...
Scientists at the Virginia Tech Carilion Research Institute have discovered how the predominant class of Alzheimer's pharmaceuticals might sharpen the brain's performance
One factor even more important than the size of a television screen is the quality of the signal it displays. Having a life-sized projection of Harry Potter dodging a Bludger in a Quidditch match is of little use if the details are lost to pixilation.
The importance of transmitting clear signals, however, is not relegated to the airwaves. The same creed applies to the electrical impulses navigating ...
A new robotic sensor deployed by Woods Hole Oceanographic Institution (WHOI) in Gulf of Maine coastal waters may transform the way red tides or harmful algal blooms (HABs) are monitored and managed in New England. The instrument was launched at the end of last month, and a second such system will be deployed later this spring.
The results will add critical data to weekly real-time forecasts of New England red tide this year distributed to more than 150 coastal resource and fisheries managers in six states as well as federal agencies such as NOAA, the FDA and the EPA. ...
GAINESVILLE, Fla. — The University of Florida today unveiled the state's most powerful supercomputer, a machine that will help researchers find life-saving drugs, make decades-long weather forecasts and improve armor for troops.
The HiPerGator supercomputer and recent tenfold increase in the size of the university's data pipeline make UF one of the nation's leading public universities in research computing.
"If we expect our researchers to be at the forefront of their fields, we need to make sure they have the most powerful tools available to science, and HiPerGator ...
LA JOLLA, CA---Scientists at the Salk Institute for Biological Studies have identified a protein that drives the formation of pituitary tumors in Cushing's disease, a development that may give clinicians a therapeutic target to treat this potentially life-threatening disorder.
The protein, called TR4 (testicular orphan nuclear receptor 4), is one of the human body's 48 nuclear receptors, a class of proteins found in cells that are responsible for sensing hormones and, in response, regulating the expression of specific genes. Using a genome scan, the Salk team discovered ...
DARIEN, IL – A new study suggests that your level of sleepiness or alertness during the day may be related to the type of food that you eat.
Results show that higher fat consumption was associated with increased objective daytime sleepiness, while higher carbohydrate intake was associated with increased alertness. There was no relationship between protein consumption and sleepiness or alertness. These findings were independent of the subjects' gender, age, and body mass index as well as the total amount of sleep they were getting and their total caloric intake.
"Increased ...
DARIEN, IL – A new study suggests that regularity of bedtime prior to initiation of continuous positive airway pressure (CPAP) therapy is an important factor that may influence treatment compliance in adults with obstructive sleep apnea (OSA).
Results show that bedtime variability was a significant predictor of CPAP adherence, which was defined as four or more hours of treatment use per night. The odds of one-month CPAP non-adherence were 3.7 times greater for every one unit increase in habitual, or pre-treatment, bedtime variability.
"Long-term use of CPAP, such as ...
This press release is available in spanish. Testing Testing Testing Testing Testing Testing Testing Testing Testing Testing Testing Testing Testing Testing
### END ...
Boston (May 7, 2013) – The first successful cornea transplant with donor endothelial tissue preloaded by an eye bank has been performed at Massachusetts Eye and Ear in Boston, Mass. Roberto Pineda II, M.D., Director of the Refractive Surgery Service at Mass. Eye and Ear, and an Associate Professor of Ophthalmology at Harvard Medical School, recently performed the groundbreaking transplant.
Dr. Pineda performed the surgery utilizing donor endothelial tissue that was prepared and pre-loaded into EndoGlide™ (Angiotech Pharmaceuticals, Inc.) cartridges at the Lions Eye Institute ...
WASHINGTON, May 7, 2013 – From New York City's Central Park to Golden Gate Park in San Francisco, America's urban forests store an estimated 708 million tons of carbon, an environmental service with an estimated value of $50 billion, according to a recent U.S. Forest Service study.
Annual net carbon uptake by these trees is estimated at 21 million tons and $1.5 billion in economic benefit.
In the study published recently in the journal Environmental Pollution, Dave Nowak, a research forester with the U.S. Forest Service's Northern Research Station, and his colleagues ...
